Immune Checkpoint Inhibitors and Vaccination: Assessing Safety, Efficacy, and Synergistic Potential.
Jacob New1,2, Luke Shenton1, Radia Ksayer3
1Department of Medicine, Scripps Health, La Jolla, CA 92121, USA.
Vaccines
|November 26, 2024
Summary
Combining immune checkpoint inhibitors (ICIs) with vaccines is safe for cancer patients, but more research is needed to confirm their effectiveness in preventing infections and improving cancer outcomes.
Area of Science:
- Oncology
- Immunology
- Vaccinology
Background:
- Immune checkpoint inhibitors (ICIs) are key cancer therapies, but their use with vaccines requires investigation.
- Existing vaccination guidelines for cancer patients may not apply with ICIs.
- Safety and efficacy data for combining ICIs with various vaccines are limited.
Purpose of the Study:
- To review the safety and efficacy of combining ICIs with infectious disease and cancer vaccines.
- To assess the impact of vaccination on infectious disease prevention in ICI-treated patients.
- To explore the potential of combining therapeutic cancer vaccines with ICIs.
Main Methods:
- Literature review of studies on ICIs combined with infectious disease vaccines (influenza, SARS-CoV-2) and therapeutic cancer vaccines.
- Analysis of safety data, including immune-related adverse events and cytokine activity.
- Evaluation of efficacy data regarding infectious disease prevention and cancer treatment outcomes.
Main Results:
- Vaccination with inactivated influenza and mRNA SARS-CoV-2 vaccines appears safe with ICI therapy.
- No apparent increase in immune-related adverse events observed with combined ICI and vaccine use.
- Limited robust evidence exists for vaccine efficacy in preventing infections or improving survival in ICI-treated patients.
- Preliminary data suggest a potential survival benefit with influenza or SARS-CoV-2 vaccination alongside ICIs, but evidence quality is low.
- Therapeutic cancer vaccines, especially mRNA-based ones, show promise when combined with ICIs, pending Phase III data.
Conclusions:
- Vaccination is generally safe for patients receiving ICI therapy.
- Further rigorous investigation is crucial to establish the efficacy of vaccines for infectious disease prevention and to optimize cancer treatment outcomes in patients on ICIs.
- The synergistic potential of combining therapeutic cancer vaccines with ICIs warrants continued research.
Related Concept Videos
01:27Tumor Immunotherapy
480
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
480
01:30Cancer Vaccines
340
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
340
01:51Vaccinations
44.1K
Overview
44.1K
01:27Cytotoxic T Cells-mediated Immune Response
849
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
849